Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Submit a comment

1,25-Dihydroxyvitamin D increases calmodulin binding to specific proteins in the chick duodenal brush border membrane.
D D Bikle, S Munson
D D Bikle, S Munson
Published December 1, 1985
Citation Information: J Clin Invest. 1985;76(6):2312-2316. https://doi.org/10.1172/JCI112241.
View: Text | PDF
Research Article

1,25-Dihydroxyvitamin D increases calmodulin binding to specific proteins in the chick duodenal brush border membrane.

  • Text
  • PDF
Abstract

In previous studies we demonstrated that the biologically active vitamin D metabolite 1,25-dihydroxyvitamin D [1,25(OH)2D] increased the calmodulin (CaM) content of chick duodenal brush border membranes (BBM) without increasing the total cellular CaM content. Therefore, we evaluated the binding of CaM to discrete proteins in the BBM and determined whether 1,25(OH)2D could influence such binding. We observed one major and several minor CaM-binding bands on autoradiograms of sodium dodecyl sulfate polyacrylamide gels incubated with [125I]CaM. The major band had a molecular weight of 102,000-105,000. It bound CaM even in the presence of EGTA, but not in the presence of trifluoperazine or excess nonradioactive CaM. The administration of 1,25(OH)2D increased the apparent binding of CaM to this protein as assessed by densitometry of the autoradiogram. This increase in CaM binding coincided with the increased ability of the same BBM vesicles to accumulate calcium. Cycloheximide in doses that markedly reduced the incorporation of [35S]methionine into BBM proteins did not reduce the ability of 1,25-dihydroxyvitamin D3 to stimulate either calcium uptake by the BBM vesicles or CaM binding to the 102,000-105,000-mol-wt protein. These results suggest that 1,25(OH)2D administration increases the CaM content of duodenal BBM by increasing the ability of a 102,000-105,000-mol-wt protein to bind CaM. This mechanism may underlie the ability of 1,25(OH)2D to stimulate calcium movement across the intestinal BBM.

Authors

D D Bikle, S Munson

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts